4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001579629-26-000008
Chief Legal Compliance Officer sold 8,829 shares at an average $30.09 ($265,628)
- Chief Legal Compliance Officer acquired 18,196 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ray Sumita · Chief Legal Compliance Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-13 | Exercise or conversion : show line 1 in the form | +18,196 | 127,374 | D | ||
| 2026-08-13 | Sale : show line 2 in the form | −2,383 | $29.37 | $69,989 | 124,991 | D |
| 2026-08-13 | Sale : show line 3 in the form | −6,442 | $30.35 | $195,515 | 118,549 | D |
| 2026-08-13 | Sale : show line 4 in the form | −4 | $31.13 | $125 | 118,545 | D |
| Open-market sales · 8,829 sh · avg $30.09 · $265,628 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-13 | Exercise or conversion : show line 5 in the form Common Stock | −18,196 | 36,393 | D |
Loading xslF345X06/form4-08172026_100832.xml…